Castelein Caley

SEC CIK: 0001355758

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

WHWK Whitehawk Therapeutics, Inc.Directoras of Jun 15, 2026
TRML Tourmaline Bio, Inc.Directoras of Oct 28, 2025
VRAY ViewRay, Inc.Directoras of Jul 21, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Castelein Caley as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

TRML Tourmaline Bio, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Oct 27, 2023 (view filing)	Oct 25-27	2 days	Castelein CaleyDirector	PPurchase	+20.0K	$14.03	+$280.6K	+4.0%516.5K after	2 lots

VRAY ViewRay, Inc.

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jul 21, 2023 (view filing)4:03 PM ET	Jul 19	2 days	Castelein CaleyDirector	SSale	−799.4K	$0.0696	−$55.6K	−89.0%99.0K after	2 lots
Jul 21, 2023 (view filing)4:03 PM ET	Jul 19	2 days	Castelein CaleyDirector	SSale	−1.55M	$0.071	−$109.7K	−100.0%0 after
May 12, 2022 (view filing)	May 10-11	2 days	Castelein CaleyDirector	PPurchase	+1.42M	$2.55	+$3.60M	+1,083.5%1.55M after	2 lots

WHWK Whitehawk Therapeutics, Inc.